NCT00994864 - Preoperative Chemosensitivity Testing to Predict Treatment Benefit in Adjuvant Stage III Colon Cancer | Biotech Hunter

Enrollment

235

Participants

Timeline

Start Date

November 30, 2009

Primary Completion Date

December 31, 2022

Study Completion Date

December 31, 2022

Conditions

Colon Cancer

Interventions

DRUG

FOLFOX

One cycle of standard FOLFOX pre-operatively followed by 11 cycles of standard adjuvant FOLFOX chemotherapy.

Trial Locations (21)

1000

Hôpital Erasme, Brussels

Jules Bordet Institute, Brussels

1020

CHU Brugmann, Brussels

1050

IRIS Etterbeek-Ixelles, Brussels

1200

Clin Université St-Luc Bruxelles, Brussels

2170

ZNA - Jan Palfijin, Merksem

2650

UZ Antwerp, Edegem

4000

CHR Citadelle de Liege, Liège

CHU De Liège, Liège

Clinique St-Joseph, Liège

5000

CHR Namur, Namur

5004

Clinique St-Luc Bouge, Bouge

5530

Clinique Universites UCL Mont-Godinne, Yvoir

7000

CHU Ambroise Paré, Mons

8400

AZ Damiaan, Ostend

8500

AZ Groeninge, Kortrijk

9000

UZ Gent, Ghent

Unknown

HIS IZZ Bracops, Brussels

Grand Hôpital Charleroi, Charleroi

clinique St Pierre Ottignies, Ottignies

AZ Turnhout, Turnhout